You're tired in a way that sleep doesn't fix. Your sex drive has flattened. You're putting on weight around the middle, losing some muscle, and your mood feels off. Somewhere along the way you read that low testosterone could explain all of it, and now you're wondering whether testosterone therapy is the answer.

It might be relevant for you. It might not. According to medical guidelines, testosterone therapy is considered only for a specific group of men, and the work that matters most happens *before* anyone writes a prescription. This article walks through how the therapy works, who it's actually considered for, the forms it comes in, and the testing and monitoring a careful provider does along the way. It's educational, not medical advice, and nothing here is a substitute for an evaluation by a licensed clinician.

What testosterone therapy is (and isn't)

Testosterone is the main male sex hormone. Your testes make it, and the brain and pituitary gland control how much. It helps maintain sex drive, sperm production, muscle, and bone health [3]. When the body doesn't make enough and a man has symptoms because of it, that's a medical condition — often called testosterone deficiency or male hypogonadism — and testosterone therapy is intended to bring levels back into a normal range as part of managing those symptoms [3].

Here's the part that surprises a lot of men: testosterone products approved by the U.S. Food and Drug Administration are cleared only for men who have low testosterone *together with an associated medical condition* — for example, the testes failing to produce testosterone, or a problem with the pituitary or hypothalamus. They are not approved for low testosterone that's simply a result of aging, and the FDA notes that the benefit and safety of these products have not been established for that use [1]. Major medical groups are blunt about this too: testosterone is not approved to boost strength, athletic performance, or appearance, and using it for those reasons may be harmful [3].

So the question isn't really "can I raise my testosterone." It's "do I have a diagnosable condition that testosterone therapy is meant to treat." That's what the evaluation is for.

Who it's considered for: symptoms plus confirmed low levels

A provider considers testosterone therapy only when two things are true at the same time.

First, you have symptoms or signs that fit. These can include low sex drive, erectile changes and loss of spontaneous erections, low energy, reduced muscle mass, breast tenderness, shrinking testes, low mood, and trouble concentrating [3]. The catch is that these symptoms are non-specific — they overlap with stress, poor sleep, depression, thyroid problems, and plenty of other conditions [2]. Feeling tired and low does not, by itself, mean low testosterone.

Second, your blood levels are genuinely low, confirmed more than once. Testosterone swings through the day — highest in the morning, lowest at night — so a single random draw isn't enough [3]. Guidelines call for at least two separate early-morning blood tests (roughly 7–10 a.m.) showing low levels before a diagnosis is made [3]. The American Urological Association uses a total testosterone below 300 ng/dL as a reasonable cutoff in support of the diagnosis, and stresses that the diagnosis is made *only* when low levels are combined with symptoms or signs — not on a number alone [2]. The American Academy of Family Physicians echoes this: the diagnosis should be made only after measurements on at least two occasions confirm low morning levels [4].

There's also a reverse case. Some conditions — unexplained anemia, bone loss, diabetes, prior chemotherapy or testicular radiation, HIV, long-term opioid or steroid use, pituitary problems — can warrant checking testosterone even without obvious symptoms [2]. And sometimes a reversible cause, like obesity, is driving low levels and should be addressed before therapy is even considered [3].

AUA Total Testosterone Cutoff Used to Support Diagnosis
Low (supports diagnosis when combined with symptoms) ≤300At or above cutoff ≤600

ng/dL · marker = AUA cutoff

Source: [2] Evaluation and Management of Testosterone Deficiency: AUA Guideline — American Urological Association

Key Numbers From the Guidelines
2Separate early-morning tests before diagnosisRoughly 7–10 a.m. [3][4]
54%Hematocrit level that's a reason to stop or adjustAbove this threshold [4]
3–6 moHold period suggested after a cardiovascular eventPer AUA [2]

Source: [2] Evaluation and Management of Testosterone Deficiency: AUA Guideline — American Urological Association, [3] Hypogonadism in Men — Endocrine Society (patient resource), [4] Testosterone Therapy: Review of Clinical Applications — American Family Physician (AAFP)

The forms testosterone therapy can take

If a provider does prescribe testosterone, there's no single "right" form. The choice depends on the cause of the low level, your preferences, cost, how your body tolerates it, and whether fertility is a concern [3]. Common FDA-approved formulations include [1][4]:

  • Topical gels and solutions — applied daily to the skin (shoulders, upper arms, underarms). Easy to use, but the medication can transfer to others through skin contact, so it has to fully absorb and be kept away from women and children [3][4].
  • Skin patches — worn daily; skin rash is a common nuisance, so application sites are rotated [4].
  • Injections — given into a muscle every one to two weeks, or a longer-acting version dosed roughly every 10 weeks; levels can rise and fall between doses [3][4].
  • Implanted pellets — placed under the skin every three to six months for steady, hands-off dosing [4].
  • A nasal gel and a buccal tablet (applied to the gum) are also available [3][4].

Each form trades convenience against things like steadier levels, skin reactions, or transfer risk — a conversation worth having rather than a default to pick.

What a provider monitors

Testosterone therapy isn't "set it and forget it." If you're prescribed it, you should expect ongoing follow-up and blood work [3]. Before starting, a provider typically checks your testosterone again, a complete blood count to measure hematocrit (the proportion of red blood cells), and prostate-specific antigen (PSA) along with a prostate exam [4].

The reason for the blood count: testosterone stimulates red blood cell production, and therapy can push the count too high (polycythemia), which is associated with a higher risk of clots [4]. Guidelines recommend measuring hematocrit at baseline, again at three to six months, then yearly — and a hematocrit above 54% is a reason to stop, lower the dose, or switch forms [4]. PSA and testosterone levels are also rechecked on a schedule [4]. The AUA advises measuring hemoglobin and hematocrit before starting and counseling patients about the polycythemia risk up front [2].

Hematocrit Monitoring Schedule on Therapy
1BaselineHematocrit measured before starting
23–6 monthsHematocrit rechecked
3YearlyHematocrit measured annually thereafter

Source: [4] Testosterone Therapy: Review of Clinical Applications — American Family Physician (AAFP)

The risks a provider weighs before prescribing

A thoughtful prescriber treats certain conditions as reasons not to start, or to proceed only with caution [3][4]:

  • Known or suspected prostate or breast cancer — testosterone therapy is not given [3][4].
  • An elevated PSA or prostate abnormality — this needs evaluation, often by a urologist, first [4].
  • A high red blood cell count (polycythemia) — a hematocrit above 54% is a clear reason not to start [4].
  • Untreated obstructive sleep apnea and uncontrolled heart failure — addressed first [4].
  • A recent heart attack or stroke — therapy is generally held for a period (the AUA suggests three to six months after a cardiovascular event) [2].
  • Wanting to father children soon — this is a big one. Testosterone therapy suppresses the body's own sperm production, so it can reduce fertility, and guidelines advise against prescribing it to men currently trying to conceive [2][4]. Men interested in fertility should have a reproductive evaluation before treatment, and there are alternative approaches a specialist can discuss [2].

On the heart-health question, the evidence has shifted. After a large FDA-required safety trial (TRAVERSE), the FDA concluded the results did not show a new signal for cardiovascular harm in men treated for low testosterone, and updated product labeling accordingly, while still noting possible blood-pressure effects [1]. The AUA's position is appropriately measured: it states it cannot be said definitively whether therapy raises or lowers cardiovascular risk, which is exactly why this is a discussion to have with a provider who knows your history [2].

The bottom line

For men who have both real symptoms and confirmed low levels, guidelines describe testosterone therapy as an option to consider when it's prescribed and monitored properly. It is not a general-purpose energy or anti-aging tool, and the medical literature cautions that starting it without a clear diagnosis carries risk without established benefit [1]. The path that medical guidelines point to is an honest evaluation: a careful symptom history, repeat morning blood tests, and a frank conversation — if testosterone therapy is prescribed — about which form fits your life, what gets monitored, and which risks apply to you.

If you'd like a more structured, modern way to work through that kind of evaluation, we're building it.

Join the waitlist to be first in line.

---

*This article is for general education and is not medical advice. It does not recommend any specific treatment, and any medication is taken only if prescribed by a licensed clinician who can evaluate your individual situation. Some testosterone products are compounded, and compounded medications are not FDA approved.*